rs138958687

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBP6BS2

The NM_000052.7(ATP7A):​c.2903A>G​(p.Glu968Gly) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000425 in 1,205,129 control chromosomes in the GnomAD database, including 1 homozygotes. There are 176 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.00047 ( 0 hom., 22 hem., cov: 22)
Exomes 𝑓: 0.00042 ( 1 hom. 154 hem. )

Consequence

ATP7A
NM_000052.7 missense

Scores

3
7
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications P:1U:1B:9

Conservation

PhyloP100: 7.36

Publications

3 publications found
Variant links:
Genes affected
ATP7A (HGNC:869): (ATPase copper transporting alpha) This gene encodes a transmembrane protein that functions in copper transport across membranes. This protein is localized to the trans Golgi network, where it is predicted to supply copper to copper-dependent enzymes in the secretory pathway. It relocalizes to the plasma membrane under conditions of elevated extracellular copper, and functions in the efflux of copper from cells. Mutations in this gene are associated with Menkes disease, X-linked distal spinal muscular atrophy, and occipital horn syndrome. Alternatively-spliced transcript variants have been observed. [provided by RefSeq, Aug 2013]
PGK1 (HGNC:8896): (phosphoglycerate kinase 1) The protein encoded by this gene is a glycolytic enzyme that catalyzes the conversion of 1,3-diphosphoglycerate to 3-phosphoglycerate. The encoded protein may also act as a cofactor for polymerase alpha. Additionally, this protein is secreted by tumor cells where it participates in angiogenesis by functioning to reduce disulfide bonds in the serine protease, plasmin, which consequently leads to the release of the tumor blood vessel inhibitor angiostatin. The encoded protein has been identified as a moonlighting protein based on its ability to perform mechanistically distinct functions. Deficiency of the enzyme is associated with a wide range of clinical phenotypes hemolytic anemia and neurological impairment. Pseudogenes of this gene have been defined on chromosomes 19, 21 and the X chromosome. [provided by RefSeq, Jan 2014]
PGK1 Gene-Disease associations (from GenCC):
  • glycogen storage disease due to phosphoglycerate kinase 1 deficiency
    Inheritance: XL Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, G2P, Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.011748552).
BP6
Variant X-78021066-A-G is Benign according to our data. Variant chrX-78021066-A-G is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 210436.
BS2
High AC in GnomAd4 at 52 XL,AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_000052.7. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP7A
NM_000052.7
MANE Select
c.2903A>Gp.Glu968Gly
missense
Exon 14 of 23NP_000043.4
ATP7A
NM_001282224.2
c.2669A>Gp.Glu890Gly
missense
Exon 13 of 22NP_001269153.1
ATP7A
NR_104109.2
n.285-10334A>G
intron
N/A

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ATP7A
ENST00000341514.11
TSL:1 MANE Select
c.2903A>Gp.Glu968Gly
missense
Exon 14 of 23ENSP00000345728.6
ATP7A
ENST00000689767.1
c.2996A>Gp.Glu999Gly
missense
Exon 16 of 25ENSP00000509406.1
ATP7A
ENST00000343533.10
TSL:5
c.2933A>Gp.Glu978Gly
missense
Exon 15 of 24ENSP00000343026.6

Frequencies

GnomAD3 genomes
AF:
0.000466
AC:
52
AN:
111480
Hom.:
0
Cov.:
22
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.000378
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00490
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000414
Gnomad OTH
AF:
0.00
GnomAD2 exomes
AF:
0.000701
AC:
128
AN:
182659
AF XY:
0.000698
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.000255
Gnomad ASJ exome
AF:
0.000401
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00543
Gnomad NFE exome
AF:
0.000305
Gnomad OTH exome
AF:
0.00177
GnomAD4 exome
AF:
0.000421
AC:
460
AN:
1093598
Hom.:
1
Cov.:
30
AF XY:
0.000428
AC XY:
154
AN XY:
359628
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
26311
American (AMR)
AF:
0.000227
AC:
8
AN:
35196
Ashkenazi Jewish (ASJ)
AF:
0.000465
AC:
9
AN:
19356
East Asian (EAS)
AF:
0.00
AC:
0
AN:
30140
South Asian (SAS)
AF:
0.000111
AC:
6
AN:
54057
European-Finnish (FIN)
AF:
0.00580
AC:
230
AN:
39631
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
4121
European-Non Finnish (NFE)
AF:
0.000223
AC:
187
AN:
838815
Other (OTH)
AF:
0.000435
AC:
20
AN:
45971
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
16
33
49
66
82
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10
20
30
40
50
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000466
AC:
52
AN:
111531
Hom.:
0
Cov.:
22
AF XY:
0.000652
AC XY:
22
AN XY:
33733
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
30685
American (AMR)
AF:
0.00
AC:
0
AN:
10444
Ashkenazi Jewish (ASJ)
AF:
0.000378
AC:
1
AN:
2648
East Asian (EAS)
AF:
0.00
AC:
0
AN:
3587
South Asian (SAS)
AF:
0.00
AC:
0
AN:
2679
European-Finnish (FIN)
AF:
0.00490
AC:
29
AN:
5922
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
217
European-Non Finnish (NFE)
AF:
0.000414
AC:
22
AN:
53146
Other (OTH)
AF:
0.00
AC:
0
AN:
1519
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.517
Heterozygous variant carriers
0
2
4
5
7
9
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000314
Hom.:
15
Bravo
AF:
0.000219
ESP6500AA
AF:
0.00
AC:
0
ESP6500EA
AF:
0.000595
AC:
4
ExAC
AF:
0.000725
AC:
88
EpiCase
AF:
0.000218
EpiControl
AF:
0.000533

ClinVar

ClinVar submissions as Germline

Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
3
not provided (4)
1
-
1
Menkes kinky-hair syndrome (2)
-
-
1
ATP7A-related disorder (1)
-
-
1
Ehlers-Danlos syndrome (1)
-
-
1
Inborn genetic diseases (1)
-
-
1
Menkes kinky-hair syndrome;C0268353:Cutis laxa, X-linked;C1845359:X-linked distal spinal muscular atrophy type 3 (1)
-
-
1
not specified (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.15
BayesDel_addAF
Benign
-0.0084
T
BayesDel_noAF
Uncertain
0.10
CADD
Uncertain
24
DANN
Uncertain
1.0
DEOGEN2
Uncertain
0.75
D
FATHMM_MKL
Pathogenic
0.99
D
LIST_S2
Uncertain
0.89
D
M_CAP
Pathogenic
0.86
D
MetaRNN
Benign
0.012
T
MetaSVM
Uncertain
0.69
D
MutationAssessor
Benign
0.090
N
PhyloP100
7.4
PrimateAI
Uncertain
0.51
T
PROVEAN
Uncertain
-3.1
D
REVEL
Pathogenic
0.70
Sift
Benign
0.13
T
Sift4G
Benign
0.28
T
Polyphen
0.89
P
Vest4
0.24
MVP
0.93
MPC
0.57
ClinPred
0.084
T
GERP RS
5.7
Varity_R
0.37
gMVP
0.90
Mutation Taster
=87/13
disease causing (ClinVar)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.030
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs138958687; hg19: chrX-77276563; API